{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:45:11Z","timestamp":1792601111635,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1053\/j.gastro.2011.02.018","type":"journal-article","created":{"date-parts":[[2011,2,19]],"date-time":"2011-02-19T05:16:02Z","timestamp":1298092562000},"page":"150-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":809,"title":["Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1\u2013Based Therapies"],"prefix":"10.1053","volume":"141","author":[{"given":"Michael","family":"Elashoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey V.","family":"Matveyenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Gier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2011.02.018_bib1","first-page":"262","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat Rev"},{"key":"10.1053\/j.gastro.2011.02.018_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/S146239940900132X","article-title":"Molecular mechanisms underlying nutrient-stimulated incretin secretion","volume":"12","author":"Parker","year":"2010","journal-title":"Exp Rev Mol Med"},{"key":"10.1053\/j.gastro.2011.02.018_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1053\/j.gastro.2011.02.018_bib4","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1210\/jc.2007-2109","article-title":"Incretin-based therapies in type 2 diabetes mellitus","volume":"93","author":"Chia","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2011.02.018_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1463-1326.2007.00765.x","article-title":"Incretin-based treatment of type 2 diabetes: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"9","author":"Deacon","year":"2007","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl","key":"10.1053\/j.gastro.2011.02.018_bib6","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2009.03.012","article-title":"Unraveling the science of incretin biology","volume":"122","author":"Nauck","year":"2009","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2011.02.018_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2337\/dc09-1499","article-title":"Incretin-based therapies for the treatment of type 2 diabetes; evaluation of the risks and benefits","volume":"33","author":"Drucker","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2011.02.018_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00125-009-1591-5","article-title":"Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?","volume":"53","author":"Butler","year":"2010","journal-title":"Diabetologia"},{"key":"10.1053\/j.gastro.2011.02.018_bib9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/diacare.29.02.06.dc05-2043","article-title":"Exenatide (exendin-4)-induced pancreatitis: a case report","volume":"29","author":"Denker","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2011.02.018_bib10","first-page":"987","article-title":"Exenatide and acute pancreatitis","volume":"56","author":"Tripathy","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"10.1053\/j.gastro.2011.02.018_bib11","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJMc0707137","article-title":"Exenatide and rare adverse events","volume":"358","author":"Cure","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2011.02.018_bib12","series-title":"Sitagliptin (marketed as Januvia and Janumet)\u2014acute pancreatitis","year":"2009"},{"key":"10.1053\/j.gastro.2011.02.018_bib13","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/dc07-2308","article-title":"Rosiglitazone and risk of cancer: a meta-analysis of randomized clinical trials","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2011.02.018_bib14","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.2337\/db09-0058","article-title":"Beneficial endocrine but adverse exocrine effects of sitagliptin in the HIP rat model of type 2 diabetes, interactions with metformin","volume":"58","author":"Matveyenko","year":"2009","journal-title":"Diabetes"},{"key":"10.1053\/j.gastro.2011.02.018_bib15","first-page":"1604","article-title":"Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas","volume":"58","author":"Nachnani","year":"2009","journal-title":"Diabetologia"},{"key":"10.1053\/j.gastro.2011.02.018_bib16","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/sj.cr.7290269","article-title":"Chronic pancreatitis, pancreatic adenocarcinoma and the black box in-between","volume":"15","author":"Jura","year":"2005","journal-title":"Cell Res"},{"key":"10.1053\/j.gastro.2011.02.018_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gut.2008.149179","article-title":"The natural history of hereditary pancreatitis: a national series","volume":"58","author":"Rebours","year":"2009","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2011.02.018_bib18","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2741\/2787","article-title":"The role of CD26\/dipeptidyl peptidase IV in cancer","volume":"13","author":"Havre","year":"2008","journal-title":"Front Biosci"},{"key":"10.1053\/j.gastro.2011.02.018_bib19","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.2174\/092986709788803114","article-title":"Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme","volume":"16","author":"Matteucci","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1053\/j.gastro.2011.02.018_bib20","series-title":"Victoza (R) (liraglutide injection): Human relevance of rodent thyroid C-cell tumors","year":"2009"},{"key":"10.1053\/j.gastro.2011.02.018_bib21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1185\/03007990902820519","article-title":"Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide","volume":"25","author":"Dore","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1053\/j.gastro.2011.02.018_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-6823-8-14","article-title":"Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis","volume":"8","author":"Williams-Herman","year":"2008","journal-title":"BMC Endocr Disord"},{"key":"10.1053\/j.gastro.2011.02.018_bib23","first-page":"BR21","article-title":"Rosiglitazone, a peroxisome proliferator-activated receptor gamma (PPARgamma)-specific agonist, as a modulator in experimental acute pancreatitis","volume":"15","author":"Celinski","year":"2009","journal-title":"Med Sci Monit"},{"key":"10.1053\/j.gastro.2011.02.018_bib24","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/MPA.0b013e3181987d9d","article-title":"Rosiglitazone aggravates nonalcoholic Fatty pancreatic disease in C57BL\/6 mice fed high-fat and high-sucrose diet","volume":"38","author":"Fernandes-Santos","year":"2009","journal-title":"Pancreas"},{"key":"10.1053\/j.gastro.2011.02.018_bib25","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2337\/diacare.25.2.298","article-title":"Obesity and treatment of diabetes with glyburide may both be risk factors for acute pancreatitis","volume":"25","author":"Blomgren","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2011.02.018_bib26","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"10.1053\/j.gastro.2011.02.018_bib27","first-page":"559","article-title":"Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes","volume":"11","author":"Shetty","year":"2005","journal-title":"J Manag Care Pharm"},{"key":"10.1053\/j.gastro.2011.02.018_bib28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/aje\/kwh161","article-title":"Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults","volume":"159","author":"Coughlin","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.gastro.2011.02.018_bib29","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00125-009-1491-8","article-title":"Collateral damage: the conundrum of drug safety","volume":"52","author":"Gale","year":"2009","journal-title":"Diabetologia"},{"key":"10.1053\/j.gastro.2011.02.018_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2165\/11531850-000000000-00000","article-title":"Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System","volume":"33","author":"Poluzzi","year":"2010","journal-title":"Drug Saf"},{"key":"10.1053\/j.gastro.2011.02.018_bib31","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1345\/aph.1L315","article-title":"Risk of hepatotoxicity associated with the use of telithromycin: a signal detection using data mining algorithms","volume":"42","author":"Chen","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.gastro.2011.02.018_bib32","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00228-004-0834-0","article-title":"Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms","volume":"60","author":"Hauben","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2011.02.018_bib33","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1331\/JAPhA.2009.09079","article-title":"Efficacy and safety of incretin based therapies: clinical trial data","volume":"49","author":"White","year":"2009","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1053\/j.gastro.2011.02.018_bib34","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.clinthera.2009.11.034","article-title":"A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus","volume":"31","author":"Montanya","year":"2009","journal-title":"Clin Ther"},{"key":"10.1053\/j.gastro.2011.02.018_bib35","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/dc10-0482","article-title":"Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis","volume":"33","author":"Garg","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1053\/j.gastro.2011.02.018_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/labinvest.2009.19","article-title":"Mechanisms of parenchymal injury and signaling pathways in ectatic ducts of chronic pancreatitis: implications for pancreatic carcinogenesis","volume":"89","author":"Bhanot","year":"2009","journal-title":"Lab Invest"},{"key":"10.1053\/j.gastro.2011.02.018_bib37","doi-asserted-by":"crossref","first-page":"E1076","DOI":"10.1152\/ajpendo.00479.2010","article-title":"Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents","volume":"299","author":"Tatarkiewicz","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1053\/j.gastro.2011.02.018_bib38","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.diabres.2010.02.017","article-title":"Inhibition of multifunctional dipeptidyl peptidase-IV: is there a risk of oncological and immunological adverse effects?","volume":"88","author":"Stulc","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1053\/j.gastro.2011.02.018_bib39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","article-title":"Antidiabetic therapies affect risk of pancreatic cancer","volume":"137","author":"Li","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.02.018_bib40","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1053\/j.gastro.2009.12.005","article-title":"Pancreatic duct glands are distinct ductal compartments that react to chronic injury and mediate Shh-induced metaplasia","volume":"138","author":"Strobel","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2011.02.018_bib41","first-page":"189","article-title":"Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies","volume":"22","author":"Li","year":"2011","journal-title":"Cancer Causes Control"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508511001727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508511001727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:58:05Z","timestamp":1758034685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508511001727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0016508511001727"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2011.02.018","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1\u2013Based Therapies","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2011.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}